Phocas Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Phocas Financial's AMRX Position: Q3 2026 in Review
Phocas Financial sold out of Amneal Pharmaceuticals (AMRX) in Q3 2026, closing a stake of 819,476 shares — an estimated $14.2M sold.
Phocas Financial first reported a position in AMRX in Q1 2019 and held it in 9 quarters. The position peaked at $16.2M in Q4 2025. 264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Phocas Financial reported no remaining Amneal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 819,476 Amneal Pharmaceuticals shares in Q3 2026, an estimated $14.2M.
- Phocas Financial first reported a position in Amneal Pharmaceuticals in Q1 2019 and held it in 9 quarters.
- Phocas Financial's Amneal Pharmaceuticals position peaked at $16.2M in Q4 2025.
- 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.